(NSCI) CALGARY, AB, Aug. 28, 2025 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable NMR spectrometers and MRI technology for industrial and research applications announces second quarter results for the period ending on June...
Related Questions
Will the Q2 revenue and profit beat expectations and how might that affect the share price in the near term?
How does Nanalysis's sales growth and new product rollouts compare to its key competitors in the portable NMR market?
What guidance does the company provide for upcoming quarters and how does it compare to analyst forecasts?